UCB Announces U.S. Launch of UCB Myasthenia Gravis Scholarship for People Impacted by Myasthenia Gravis in the U.S.

PR Newswire10/16 02:00

Oruka Draws Buy at Stifel on Potential Against Psoriasis

Seeking Alpha10/12 03:28

Biogen, UCB Mark Late-stage Trial Win for Autoimmune Disease Therapy

Seeking Alpha09/24 18:41

UCB And Biogen Report Results In Phase 3 Lupus Drug Trial

Benzinga09/24 14:48

UCB Gets Expanded FDA Approval for Psoriasis Drug Bimzelx

Seeking Alpha09/24 03:17

Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB

Benzinga08/30 00:29